Skip to content
Screener

Axsome Therapeutics AXSM Book value per share

Book value per share at other companies

Eli Lilly logo
Eli LillyLLY
$37.91+86.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$34.82+7.3%
Alkermes logo
AlkermesALKS
$10.43+8.0%
AbbVie logo
AbbVieABBV
-$3.75-568%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$12.47+55.3%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$15.49+25.8%

Other financials

Income statement

See full
Revenue$191.2M+57.4%
Gross profit$176.5M+58.0%
Operating income-$63.4M-11.2%
Net income-$64.5M-8.6%
EPS (diluted)-$1.26-3.3%

Balance sheet

See full
Cash & equivalents$305.1M+1.4%
Total debt$219.9M+4.1%
Total equity$54.6M+2.6%
Total assets$713.6M+19.6%

Cash flow

See full
Operating cash flow-$20.7M+52.3%
CapEx$121.0K-64.2%
Free cash flow-$20.8M+52.4%

Valuation

See full
Market cap$10.95B+113%
Enterprise value$10.87B+114%
P/S15.5×+5.1×

Profitability

See full
Gross margin92.6%+1.1pp
Operating margin-24.4%-9.3pp
Net margin-26.6%-9.8pp
FCF margin-10.2%-3.9pp

Returns & leverage

See full
Return on equity-349.4%+109pp
Debt / equity+0.1×
Current ratio1.4×-0.6×

Where this comes from

Calculated from Axsome Therapeutics’s reported figures.

Based on the most recent quarter.

The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →

Filed
May 4, 2026, 5:04 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-204274

FAQ

What is Axsome Therapeutics's book value per share?
Axsome Therapeutics (AXSM) reported book value per share of $1.07 in Q1 2026.
How has Axsome Therapeutics's book value per share changed year-over-year?
Axsome Therapeutics's book value per share decreased by 2.1% year-over-year, from $1.09 to $1.07.
What is the long-term trend for Axsome Therapeutics's book value per share?
Over 5 years (2020 to 2025), Axsome Therapeutics's book value per share has grown at a -10.3% compound annual growth rate (CAGR), from $3.06 to $1.77.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Axsome Therapeutics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude